Lundbeck's Phase IV THRIVE Trial Results Show Promise for Eptinezumab in Migraine Treatment #Denmark #Lundbeck #Valby #Vyepti #Eptinezumab

Lundbeck's Phase IV THRIVE Trial Reveals Promising Results for VYEPTI® in Migraine Patients #Denmark #Lundbeck #Valby #Migraine #Vyepti